1997
DOI: 10.1590/s0104-42301997000300002
|View full text |Cite
|
Sign up to set email alerts
|

Uso do suporte ventilatório com pressão positiva contínua em vias aéreas (CPAP) por meio de máscara nasofacial no tratamento da insuficiência respiratória aguda

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2010
2010
2010
2010

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
1
0
1
Order By: Relevance
“…The ability of continuous positive airway pressure to recruit collapsed alveolar units, explains the reduction of the shunt, thereby improving respiratory mechanics, oxygenation and reducing the overload on the cadiovascular system [22][23][24] . Some studies have shown beneficial effects of using continuous positive airway pressure (CPAP) 18,25 with improved levels of PaO 2 and decrease in RR in patients with respiratory failure 26 . In cardiac patients there was initial suggestions of poor results with two levels of positive airway pressure (BIPAP) 27 , which was not confirmed later 28 .…”
mentioning
confidence: 99%
“…The ability of continuous positive airway pressure to recruit collapsed alveolar units, explains the reduction of the shunt, thereby improving respiratory mechanics, oxygenation and reducing the overload on the cadiovascular system [22][23][24] . Some studies have shown beneficial effects of using continuous positive airway pressure (CPAP) 18,25 with improved levels of PaO 2 and decrease in RR in patients with respiratory failure 26 . In cardiac patients there was initial suggestions of poor results with two levels of positive airway pressure (BIPAP) 27 , which was not confirmed later 28 .…”
mentioning
confidence: 99%
“…Existem muitos estudos sobre o uso da máscara facial com pressão positiva contínua em vias aéreas em pacientes com insuficiência respiratória aguda tanto de origem cardíaca quanto pulmonar (Bernsten et al, 1991;Meduri et al, 1994Meduri et al, , 1996Brochard et al, 1995;Ambrosino, 1996;Scarpinella-Bueno et al, 1997;Delelaux et al, 2000;Antonelli et al, 1998Antonelli et al, , 2000Antonelli et al, , 2001Brochard, 2002), e sobre pacientes oncológicos, a maioria em pacientes neutropênicos e imunocomprometidos (Mehta e Hill, 2001;Hilbert et al, 2001).…”
Section: Confortounclassified